Background & Objective: Comparative molecular field analysis (CoMFA) of 27 analogues
of 2-((pyridin-3-yloxy)methyl)piperazine derivatives was carried out using software Tripos SYBYL X.
Optimal r2 (0.854) and q2 (0.541) values were obtained for the developed 3D-QSAR model. The contour
plots obtained from CoMFA analysis have shown 13.84% steric contribution and 66.14% electrostatic
contribution towards an anti-inflammatory activity.
Methods: The homology model of the receptor protein, α7 nicotinic acetylcholine, was generated in
SWISS MODELLER using auto template mode and was analysed for the quality using Procheck,
QMEAN Z-score, Anolea and GROMOS plots. The QMEAN score for the model was observed to be -
3.862. The generated model of alpha 7 nicotinic acetylcholine receptor was used for docking study of
27 piperazine analogues using Auto-Dock 126.96.36.199.
Results: The dock score obtained from docking analysis was then correlated with experimental pIC50
values for in-silico validation of the developed CoMFA model and a good correlation was obtained
with correlation coefficient (r2) value of -0.7378.
Conclusion: The present investigation suggests an optimal 3D-QSAR with CoMFA model for further
evaluating new chemical entities based on piperazine skeleton.